Among the DNMT inhibitors known till date, epigallocathechin-3-gallate (EGCG) was identified to be effective in reducing DNMT activity. However,the broad spectrum of EGCG to other diseases and variable target enzymes offers some limitations.
Among the DNMT inhibitors known till date, epigallocathechin-3-gallate (EGCG)was identified to be effective in reducing DNMT activity. However,the broad spectrum of EGCG toother diseases and variable target enzymes offers some limitations.